Volume 24, Issue 4

OpenAI, an artificial intelligence (“AI”) developer, captured the attention of technology companies, consumers, and policymakers when it released an updated version of its AI-enabled chatbot ChatGPT in December 2022. Weeks after the release, a Member of Congress introduced a non-binding resolution calling for a nimble and flexible government agency to oversee AI development to manage …

For years, entrepreneurs have raised capital from angel investors and venture capitalists through staged financings. In each round of financing, the entrepreneur recruits a lead investor who negotiates the deal terms of the investment on behalf of all investors. From there, the lead investor assists the startup venture by recruiting other investors to join them …

“The only way that you can truly feel secure while using these DeFi products currently is to trust in the competency of the team and their ability to secure their admin key.”-DeFi Watch This Article discusses the possible practical legal enforcement of disputes on an Ethereum blockchain. It contains two key ideas that may help …

Organ bioprinting involves using cells and biomaterials to 3D print structures that resemble and imitate the functions of natural organs. Since bioprinting is a relatively new technological advancement, there is a lack of regulatory structure in the United States, despite regulatory structures around the globe that are more developed in this field. Because of bioprinting’s …

Artificial intelligence (“AI”) has the potential to revolutionize entire industry sectors and provide substantial economic and social benefits to American works and consumers. Although the AI legal and regulatory landscape is still in its early stages and the regulatory void seems to be widening, many private initiatives have embraced self-regulation to foster responsible AI development …